What's in Balmoral Medical company's pipeline?

Balmoral Medical company has 6 drugs in our index: 1 marketed, 0 filed, 5 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Balmoral Medical company's portfolio?

Top competitors by shared drug class: LEO Pharma, AstraZeneca, GlaxoSmithKline, InventisBio Co., Ltd, Addpharma Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/balmoral-medical-company.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Balmoral Medical company — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Balmoral Medical company pipeline: 1 marketed, 0 filed, 5 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 5 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Metronidazole Vaginal Gel 0.75%	Metronidazole Vaginal Gel 0.75%	marketed	Nitroimidazole antibiotic	Bacterial DNA	Infectious Disease
GDC 695	GDC 695	phase 3	PI3K delta inhibitor	PI3K delta (p110δ)	Immunology
GDC-229	GDC-229	phase 3	PI3K inhibitor	PI3K	Oncology
Clindamycin Phosphate Lotion 1%	Clindamycin Phosphate Lotion 1%	phase 3	Lincosamide antibiotic	Bacterial 50S ribosomal subunit	Dermatology
GDC Vehicle Lotion	GDC Vehicle Lotion	phase 3			Dermatology
GDC 268 Lotion	GDC 268 Lotion	phase 3	corticosteroid		Dermatology

Therapeutic area mix

Dermatology · 3
Immunology · 1
Infectious Disease · 1
Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

LEO Pharma · 2 shared drug classes
AstraZeneca · 2 shared drug classes
GlaxoSmithKline · 2 shared drug classes
InventisBio Co., Ltd · 2 shared drug classes
Addpharma Inc. · 2 shared drug classes
AmMax Bio, Inc. · 1 shared drug class
Allergan · 1 shared drug class
Ahn-Gook Pharmaceuticals Co.,Ltd · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Balmoral Medical company:

Cite this brief

Drug Landscape (2026). Balmoral Medical company — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/balmoral-medical-company. Accessed 2026-05-17.